MyLumineyes ResearchI-STROMALResearch v1.5
Iris structure · Longitudinal morphology · Research hypothesis

I-STROMAL: Iris Stromal Structural Resilience Following Selective Melanin Modulation

A testable framework asking whether baseline iris architecture explains longitudinal structural outcomes beyond pigmentation and initial anatomical measurements.

Mustafa Mete, MD · MyLumineyes Research · ORCID 0009-0004-3128-2853

Persistent identifier10.5281/zenodo.23645435Reserved DOI; activation follows Zenodo publication
Version / dateResearch version 1.5 · 25 October 2026
Research focusLongitudinal stromal morphology · H2
Research overview

One narrow question, three independently measurable dimensions

I-STROMAL is a proposed framework for investigating how the anatomical iris stroma can be characterized over time after selective pigment modification. Its immediate question is not whether a laser procedure has already been proven structurally harmless or harmful. It is whether baseline architectural descriptors add reproducible information about subsequent morphology after pigmentation and initial measurements are considered.

Does baseline stromal architecture provide meaningful information about longitudinal structural outcomes beyond apparent pigmentation, initial morphology and relevant clinical characteristics?

Visible pigment reduction is not a direct measurement of connective-tissue preservation. Equally, a stable iris thickness measurement does not establish melanocyte viability, collagen organization or complete ocular safety. These distinctions motivate separate observation of pigmentation, anatomy and clinical findings.

Scientific provenance

Contribution within the research programme

Earlier work has already linked iris surface architecture to physiological volume changes during pupil dilation, and swept-source AS-OCT studies have quantified sectoral variation in human iris morphology. These findings provide important precedents for the study of longitudinal structural outcomes [2–4].

The proposed distinct contribution is the post-modulation structural endpoint and the requirement to test whether independently characterized baseline architectural features supply additional explanatory or predictive value. A statistical model comparison is a means of testing this proposition, not itself a biological discovery.

LIPS · Pigmentation

Visible baseline phenotype

Describes clinically apparent anterior stromal pigmentation. Grades I–IV form an ordered diffuse spectrum; Grade V is a distinct heterogeneous phenotype, not a darker fifth level.

L-OAT · Architecture

Reproducible feature space

Proposes separate visible, architectural and OCT-signal domains, subject to measurement reliability and calibration constraints.

I-STROMAL · Longitudinal outcome

Independent structural response

Asks whether baseline architecture adds information about subsequent measurable morphology once existing baseline information is taken into account.

The complementary Beyond Melanin Clearance research examines cellular communication and extracellular-matrix biology. I-STROMAL concentrates on measurable longitudinal stromal morphology. The framework was developed within the research context of the Lumineyes™ approach and its Selective Stromal Melanin Modulation (SSMM) model.

Research architecture

Primary hypothesis H2: independent architectural contribution

Two comparable statistical models would be evaluated against the same prespecified longitudinal structural outcome. The expanded model must demonstrate improvement beyond additional complexity, measurement redundancy and overfitting.

Research architecture · H2Baseline information and independently measured longitudinal structural outcomes
Domain PBaseline pigmentation

LIPS and appropriately standardized visible phenotype

Baseline endpointInitial iris morphology

Predefined anatomical value under documented pupil state

Domain ANon-redundant architecture

Predefined crypt, contour or other independently validated descriptors

Reference model · A
Baseline information

Visible pigmentation + initial value of structural endpoint + relevant clinical covariates.

Architecture-enhanced model · B
Model A + independent architecture

Identical baseline variables, plus predefined architectural descriptors with measurement reliability established.

Shared longitudinal structural endpoint

Prespecified morphological change; uncertainty, pupil-state effects, segmentation and participant clustering explicitly considered.

Figure 1. Proposed comparison of reference and architecture-enhanced models using a shared longitudinal structural endpoint.
A useful study should distinguish baseline prediction using information available before exposure from a separate explanatory analysis that considers subsequently observed pigmentary changes or documented exposure characteristics.
Testability

Three propositions, different evidentiary requirements

H1 · Secondary

Pigmentary–structural dissociation

Comparable visible pigment changes may coexist with different independently measured morphological outcomes. Proportional, tightly coupled responses would challenge this proposition.

H2 · Primary

Independent architectural contribution

Non-redundant baseline features may improve validated performance beyond pigmentation and initial morphology. Repeated failure to add information would weaken the hypothesis.

H3 · Exploratory

Temporal dissociation

Visible pigmentary and morphological measurements may evolve over different time courses. Consistently synchronous trajectories would challenge the proposed temporal distinction.

Support for any one hypothesis does not automatically support the others. The framework should remain open to revision or rejection if adequately measured observations do not reproduce its predictions.

I-STROMAL research framework infographic outlining the H2 architectural contribution hypothesis, LIPS and L-OAT, three possible structural outcomes, and longitudinal iris imaging methods
Figure 2. Research overview linking baseline iris architecture, the primary H2 hypothesis and longitudinal assessment domains.
Interpretive categories

Three possible structural observations—not a mandatory sequence

01

Architectural preservation

Selected morphological measurements remain stable within prospectively justified measurement limits. This is not proof of complete microscopic preservation.

02

Adaptive morphological change

Reproducible anatomical variation without independently established pathological significance. The term does not establish fibroblast remodeling or regeneration.

03

Pathological alteration

Reproducible structural abnormalities supported by evidence of injury or clinically relevant deterioration. No universal mechanism or inevitability is presumed.

Categories may vary by iris region and observation interval. They do not designate obligatory stages, fixed treatment thresholds or probabilities of harm.

Measurement discipline

What a longitudinal test must control

The biological question cannot be answered reliably unless the measurement system is characterized first. AS-OCT-derived morphology is influenced by tissue optical properties, pupil state, imaging geometry and segmentation conditions [2,3,5].

DomainCandidate informationRequired interpretation
Baseline pigment phenotypeLIPS I–IV and separate Grade V heterogeneity designationAppearance descriptor; not a direct measure of melanin mass
Initial structural endpointPrespecified regional thickness or another measurable anatomical featureReference-model baseline value; not interchangeable with later outcome
Independent architectureCrypt distribution or non-redundant geometric descriptorsCandidate added variables; require reliability and independent definition
Pigmentary responseStandardized photography and qualified colorimetry [6]Separate longitudinal outcome, not a histological measure
Structural responsePrespecified follow-up AS-OCT morphologyMeasurement uncertainty, pupillary state, boundary visibility and segmentation considered
Model comparisonReference Model A versus architecture-enhanced Model BIncremental performance requires appropriate validation; no automatic causal inference

Table 1. Variables and interpretation criteria for longitudinal evaluation of iris stromal architecture.

Optical visibility

AS-OCT is not histology

Pigmentation can affect signal penetration and the reliability of posterior boundary identification. A newly visible boundary must not automatically be classified as tissue thickening or thinning.

Measurement validity

No stability from P > 0.05

A nonsignificant difference alone does not establish structural equivalence. Repeated acquisitions, confidence intervals, limits of agreement and predefined meaningful-change criteria are needed.

Scholarly record

Original preprint and citation

Mete M. Iris Stromal Structural Resilience Following Selective Melanin Modulation: A Conceptual Framework (I-STROMAL). Research manuscript. Version 1.5. MyLumineyes Research; 2026. Reserved DOI: 10.5281/zenodo.23645435.

Funding: No external grant. Competing interests: The author developed the Lumineyes™ approach and proposed the associated research frameworks.

Selected references

Research and methodological sources

  1. Makovoz B, et al. Human iris single-cell characterization. Nature Communications. 2025;16:10648. DOI.
  2. Invernizzi A, et al. Three-dimensional morphometric analysis of the iris by swept-source AS-OCT. Invest Ophthalmol Vis Sci. 2015;56:4796–4801. DOI.
  3. Mak H, et al. Imaging the iris with swept-source OCT. Ophthalmology. 2013;120:2517–2524. PubMed.
  4. Chua J, et al. Iris crypts influence dynamic changes of iris volume. Ophthalmology. 2016;123:2077–2084. PubMed.
  5. Chen H, et al. Segmentation errors in swept-source AS-OCT volumetric parameters. Front Med. 2021;8:761550. DOI.
  6. Edwards M, et al. Quantitative measures of iris color using high-resolution photographs. Am J Phys Anthropol. 2012;147:141–149. PubMed.
  7. Yildirim Y, et al. Evaluation of color-changing effect after Nd:YAG laser application on iris surface: animal experiment. Med Sci Monit. 2016;22:107–114. PubMed.
Lumineyes Lumineyes Assistant ×
Structured clinical guidance • No automated free-text answers
Start Here
Ask a question or choose a topic above.
Explore how Lumineyes works, treatment sessions, results, safety, eligibility, cost, and appointments.